(Q83144837)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16609811%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Mitoxantrone versus cyclophosphamide in secondary-progressive multiple sclerosis: a comparative study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16609811%20AND%20SRC:MED&resulttype=core&format=json

secondary progressive multiple sclerosis

19 January 2020

main subject

0 references

author name string

Paola Perini

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16609811%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Massimiliano Calabrese

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16609811%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Michela Tiberio

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16609811%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Federica Ranzato

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16609811%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Leontino Battistin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16609811%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Paolo Gallo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16609811%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

11 April 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16609811%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16609811%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

253

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16609811%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16609811%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

1034-1040

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16609811%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00415-006-0154-7

19 January 2020

exact match

0 references

cites work

Treatment of progressive multiple sclerosis with pulse cyclophosphamide/methylprednisolone: response to therapy is linked to the duration of progressive disease

1 reference

12 December 2020

Safety and tolerability of cyclophosphamide 'pulses' in multiple sclerosis: a prospective study in a clinical cohort.

1 reference

12 December 2020

Effect of monthly intravenous cyclophosphamide in rapidly deteriorating multiple sclerosis patients resistant to conventional therapy

1 reference

12 December 2020

Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial

1 reference

12 December 2020

The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis. The Canadian Cooperative Multiple Sclerosis Study Group

1 reference

12 December 2020

Mitoxantrone as rescue therapy in worsening relapsing-remitting MS patients receiving IFN-beta

1 reference

12 December 2020

Stabilization of rapidly worsening multiple sclerosis for 36 months in patients treated with interferon beta plus cyclophosphamide followed by interferon beta

1 reference

12 December 2020

One-year cyclophosphamide treatment combined with methylprednisolone improves cognitive dysfunction in progressive forms of multiple sclerosis

1 reference

12 December 2020

1 reference

12 December 2020

Treatment of progressive forms of multiple sclerosis by cyclophosphamide: a cohort study of 490 patients

1 reference

12 December 2020

Defining the clinical course of multiple sclerosis: Results of an international survey

1 reference

12 December 2020

Mitoxantrone therapy in multiple sclerosis and acute leukaemia: a case report out of 644 treated patients

1 reference

12 December 2020

Immune deviation following pulse cyclophosphamide/methylprednisolone treatment of multiple sclerosis: Increased interleukin-4 production and associated eosinophilia

1 reference

12 December 2020

Intense immunosuppression in chronic progressive multiple sclerosis: the Kaiser study

1 reference

12 December 2020

Preliminary analysis of a trial of pulse cyclophosphamide in IFN-beta-resistant active MS.

1 reference

12 December 2020

Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment Group

1 reference

12 December 2020

Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.

1 reference

12 December 2020

Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria

1 reference

12 December 2020

Mitoxantrone for multiple sclerosis in clinical practice

1 reference

12 December 2020

Cyclophosphamide is effective in stabilizing rapidly deteriorating secondary progressive multiple sclerosis

1 reference

12 December 2020

Mitoxantrone treatment of multiple sclerosis: safety considerations

1 reference

12 December 2020

Acute myeloid leukaemia induced by mitoxantrone in a multiple sclerosis patient

1 reference

12 December 2020

Multiple sclerosis: long-term remission after a high dose of cyclophosphamide

1 reference

12 December 2020

Review of mitoxantrone in the treatment of multiple sclerosis

1 reference

12 December 2020

The combination of cyclophosphamide plus interferon beta as rescue therapy could be used to treat relapsing-remitting multiple sclerosis patients-- twenty-four months follow-up.

1 reference

12 December 2020

Mitoxantrone: a review of its use in multiple sclerosis

1 reference

12 December 2020

The use of mitoxantrone (Novantrone) for the treatment of multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

1 reference

12 December 2020

Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy

1 reference

12 December 2020

Severe delayed heart failure in three multiple sclerosis patients previously treated with mitoxantrone.

1 reference

12 December 2020

Clinical practice of immunosuppressive treatments in multiple sclerosis: results of a second international questionnaire

1 reference

12 December 2020

Immunosuppressive treatment in multiple sclerosis

1 reference

12 December 2020

Effect of open label pulse cyclophosphamide therapy on MRI measures of disease activity in five patients with refractory relapsing-remitting multiple sclerosis.

1 reference

12 December 2020

Pulse cyclophosphamide plus methylprednisolone induces myelin-antigen-specific IL-4-secreting T cells in multiple sclerosis patients

1 reference

12 December 2020

Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome

1 reference

12 December 2020

[Early results of the treatment of chronic progressive forms of multiple sclerosis with cyclophosphamide and ACTH]

1 reference

12 December 2020

Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects

1 reference

12 December 2020

Cyclophosphamide therapy for MS.

1 reference

12 December 2020

A pilot trial of combination therapy with mitoxantrone and interferon beta-1b using monthly gadolinium-enhanced magnetic resonance imaging

1 reference

12 December 2020